Reaction
Necrotising Oesophagitis reporting signals
As of the last recalculation, Necrotising Oesophagitis appears in 485 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is MICAFUNGIN SODIUM (PRR 72.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Micafungin Sodium | 14 | 72.9 | 73.1 |
| Metolazone | 16 | 63.1 | 63.2 |
| Tacrolimus Ointment 0.1% | 89 | 37.3 | 37.4 |
| Tacrolimus Extended-Release Capsules | 89 | 37.2 | 37.3 |
| Norepinephrine | 9 | 36.8 | 36.8 |
| Norepinephrine Bitartrate | 12 | 36.7 | 36.7 |
| Mycophenilic Acid | 17 | 36.4 | 36.5 |
| Cefazolin | 7 | 33.4 | 33.4 |
| Canagliflozin | 22 | 33.0 | 33.0 |
| Tacrolimus | 94 | 31.7 | 31.7 |
| Glimepiride | 23 | 26.5 | 26.6 |
| Pioglitazone | 22 | 22.8 | 22.8 |
| Cetuximab | 14 | 19.7 | 19.7 |
| Oxaliplatin | 30 | 18.4 | 18.4 |
| Crizotinib | 5 | 17.0 | 17.1 |
| Irinotecan Hydrochloride | 5 | 16.9 | 16.9 |
| Remdesivir | 5 | 16.3 | 16.3 |